For instance, the hypermethylation of Prostaglandin E Receptor 4 (PTGER4) in the plasma was shown to distinguish patients with lung cancer from those with COPD or benign lung lesions [138]. This evidence concerns the gene PTGER4 and chronic obstructive pulmonary disease.